Science Explorer Back to mapMap

Most cited papers from HAL Allergy (Netherlands)

What are the most cited papers from HAL Allergy (Netherlands)?

The most cited paper from HAL Allergy (Netherlands) is "EU Forum: The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification" (Ronald van Ree et al., 2008), with 196 citations. Next come "Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells" (165) and "Children with peanut allergy recognize predominantly Ara h2 and Ara h6, which remains stable over time" (147).

Showing 50 of 77 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 EU Forum: The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification Ronald van Ree et al. · Allergy 4 Feb 2008 196
2 Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells Angelic M.G. van der Aar, Darya S. Sibiryak, Ghaith Bakdash et al. · Journal of Allergy and Clinical Immunology Open access 19 Apr 2011 165
3 Children with peanut allergy recognize predominantly Ara h2 and Ara h6, which remains stable over time Annebeth E. Flinterman, Els van Hoffen, Constance F. den Hartog Jager et al. · Clinical & Experimental Allergy 16 Jun 2007 147
4 Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy? K. A. B. M. Peeters, Stef J. Koppelman, Els van Hoffen et al. · Clinical & Experimental Allergy 20 Dec 2006 136
5 Intraday analysis of market integration: Dutch blue chips traded in Amsterdam and New York Erik C.J. Hupperets, Albert J. Menkveld · Journal of Financial Markets Open access 2002 116
6 Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy Laurian Zuidmeer et al. · International Archives of Allergy and Immunology Open access 2015 108
7 Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy Ronald van Ree, W. Astrid van Leeuwen, Paul H. Dieges et al. · Clinical & Experimental Allergy Open access 1997 97
8 Anaphylaxis from Passive Transfer of Peanut Allergen in a Blood Product Joannes F.M. Jacobs, Joseph L. Baumert, Paul Brons et al. · New England Journal of Medicine Open access 18 May 2011 74
9 Manufacturing a chimpanzee adenovirus‐vectored SARS‐CoV‐2 vaccine to meet global needs Carina C. D. Joe et al. · Biotechnology and Bioengineering Open access 29 Sep 2021 68
10 Biomarkers in asthma and allergic rhinitis Zuzana Diamant, Johan Diderik Boot, E C Mantzouranis et al. · Pulmonary Pharmacology & Therapeutics Jul 2010 68
11 FAST: towards safe and effective subcutaneous immunotherapy of persistent life‐threatening food allergies Laurian Zuidmeer et al. · Clinical and Translational Allergy Open access 2012 67
12 Allergenicity attributes of different peanut market types Stef J. Koppelman, Shyamali Jayasena, Dion M.A.M. Luykx et al. · Food and Chemical Toxicology 26 Feb 2016 64
13 ASSURE‐CSU: a real‐world study of burden of disease in patients with symptomatic chronic spontaneous urticaria Karsten Weller, Marcus Maurer, C Grattan et al. · Clinical and Translational Allergy Open access 2015 62
14 Efficacy and Safety of a Glutaraldehyde-Modified House Dust Mite Extract in Allergic Rhinitis Herbert Riechelmann, Joachim Schmutzhard, Jan F. van der Werf et al. · American Journal of Rhinology and Allergy Sep 2010 59
15 Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma Oliver Pfaar, Claus Bachert, Piotr Kuna et al. · Journal of Allergy and Clinical Immunology Open access 30 Nov 2018 50
16 A randomized, 5‐arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients Oliver Pfaar, M. J. Nell, Johan Diderik Boot et al. · Allergy Open access 11 Feb 2016 50
17 Reduction and alkylation of peanut allergen isoforms Ara h 2 and Ara h 6; characterization of intermediate- and end products Danijela Apostolović, Dion M.A.M. Luykx, Hans Warmenhoven et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 18 Oct 2013 50
18 Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects Jan Ceuppens, Dominique M. A. Bullens, Huub A.J. Kleinjans et al. · Clinical & Experimental Allergy 13 Nov 2009 48
19 A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT ‐birch pollen extract for the treatment of allergic rhinitis: results of a phase II study Oliver Pfaar, Esther van Twuijver, Johan Diderik Boot et al. · Allergy Open access 3 Sep 2015 48
20 Chemically modified peanut extract shows increased safety while maintaining immunogenicity Hanneke P. M. van der Kleij, Hans Warmenhoven, Ronald van Ree et al. · Allergy Open access 2 Dec 2018 47
21 Ara h 6 Complements Ara h 2 as an Important Marker for IgE Reactivity to Peanut Audrey Koid, Martin D. Chapman, Robert G. Hamilton et al. · Journal of Agricultural and Food Chemistry Open access 11 Dec 2013 45
22 Measuring parvalbumin levels in fish muscle tissue: Relevance of muscle locations and storage conditions Poi-Wah Lee, Julie A. Nordlee, Stef J. Koppelman et al. · Food Chemistry 11 May 2012 39
23 Masking foods for food challenge: Practical aspects of masking foods for a double-blind, placebo-controlled food challenge Geertje B Huijbers, Ann A.M Colen, Jeannette J Niestijl Jansen et al. · Journal of the American Dietetic Association Jun 1994 34
24 SCIT-treatment With a Chemically Modified, Aluminum Hydroxide Adsorbed Peanut Extract (HAL-MPE1) Was Generally Safe And Well Tolerated And Showed Immunological Changes In Peanut Allergic Patients Carsten Bindslev‐Jensen, Pieter‐Jan de Kam, Esther van Twuijver et al. · Journal of Allergy and Clinical Immunology Feb 2017 29
25 Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Grass Pollen Preparation Oliver Pfaar, Esther van Twuijver, Heike Hecker et al. · International Archives of Allergy and Immunology 23 Nov 2012 28
26 Basophil response to peanut allergens in Mediterranean peanut‐allergic patients Cristobalina Mayorga, F. Gómez, Ana Aranda et al. · Allergy 12 May 2014 28
27 Parvalbumin in fish skin-derived gelatin: is there a risk for fish allergic consumers? Stef J. Koppelman, Julie A. Nordlee, Poi‐Wah Lee et al. · Food Additives & Contaminants Part A 24 Jul 2012 27
28 Patient knowledge, perceptions, expectations and satisfaction on allergen-specific immunotherapy: A survey Ilaria Baiardini, Francesca Puggioni, Stefania Menoni et al. · Respiratory Medicine Open access 4 Dec 2012 27
29 Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma Daniel J. Jackson et al. · Annals of Allergy Asthma & Immunology Open access 22 Mar 2023 24
30 Controlling the aggregation propensity and thereby digestibility of allergens by Maillardation as illustrated for cod fish parvalbumin Harmen H. J. de Jongh, Steve L. Taylor, Stef J. Koppelman · Journal of Bioscience and Bioengineering 22 Oct 2010 24
31 The CREATE Project: Development of Certified Reference Materials for Allergenic Products and Validation of Methods for Their Quantification Ronald van Ree et al. · Advanced topics in science and technology in China Book chapter 2012 23
32 Evaluation and Comparison of the Species-Specificity of 3 Antiparvalbumin IgG Antibodies Poi-Wah Lee, Julie A. Nordlee, Stef J. Koppelman et al. · Journal of Agricultural and Food Chemistry 15 Oct 2011 23
33 COVID‐19 vaccines: the importance of transparency and fact‐based education Adam F. Cohen, Joop van Gerven, Juan García Burgos et al. · British Journal of Clinical Pharmacology Open access 14 Oct 2020 22
34 Effect of chemical modifications on allergenic potency of peanut proteins Ramon Bencharitiwong, Hanneke P. M. van der Kleij, Stef J. Koppelman et al. · Allergy and Asthma Proceedings Open access May 2015 22
35 IgE cross-inhibition between Ara h 1 and Ara h 2 is explained by complex formation of both major peanut allergens Hans Warmenhoven, Luuk Hulsbos, Stephen C. Dreskin et al. · Journal of Allergy and Clinical Immunology Open access 5 Apr 2023 17
36 Open‐label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients Juliane Rieker‐Schwienbacher, Marja J. Nell, Zuzana Diamant et al. · Clinical and Translational Allergy Open access 2013 16
37 Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen Rob G. J. A. Zuiker, Marcella K. Ruddy, Nicoletta Morelli et al. · European Clinical Respiratory Journal Open access 2015 15
38 Distribution of Intact Peanut Protein and Digestion-Resistant Ara h 2 Peptide in Human Serum and Saliva Joseph L. Baumert, Robert K. Bush, M.B. Levy et al. · Journal of Allergy and Clinical Immunology Feb 2009 15
39 Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Birch Pollen Preparation Krzysztof Buczyłko, Jan F. van der Werf, Diderik Boot et al. · International Archives of Allergy and Immunology Open access 2017 14
40 Birch Pollen Immunotherapy in Mice: Inhibition of Th2 Inflammation Is Not Sufficient to Decrease Airway Hyper-Reactivity Leonie S. van Rijt, L. Utsch Mendes Gouveia, Adrian Logiantara et al. · International Archives of Allergy and Immunology 2014 14
41 Chemical modification of peanut conglutin reduces I g E reactivity but not T cell reactivity in peanut‐allergic patients Els van Hoffen, Hanneke P. M. van der Kleij, Constance F. den Hartog Jager et al. · Clinical & Experimental Allergy 9 Apr 2014 13
42 Grass pollen immunotherapy induces highly cross‐reactive IgG antibodies to group V allergen from different grass species Ronald van Ree, Piotr Z. Brewczyński, K. Y. Tan et al. · Allergy Mar 1995 13
43 A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations Ludger Klimek, Annette Sperl, Esther van Twuijver et al. · Clinical and Translational Allergy Open access 2014 11
44 Sputum induction with hypertonic saline reduces fractional exhaled nitric oxide in chronic smokers and non-smokers Rob G. J. A. Zuiker, Johan Diderik Boot, César Augusto Angulo Calderón et al. · Respiratory Medicine Open access 15 Mar 2010 11
45 Characterization of Modified Allergen Extracts by in vitro β-Hexosaminidase Release from Rat Basophils Kirsten Gehlhar, Marcus Peters, Kirsten Brockmann et al. · International Archives of Allergy and Immunology 2005 10
46 House dust mite-specific IgA2 is associated with protection against eczema in allergic patients Gerco den Hartog, R. J. Joost van Neerven, Johan Diderik Boot et al. · Allergy Open access 19 Nov 2015 9
47 Development Of A Subcutaneous Immunotherapy (SCIT) With A Modified Peanut Extract Formulation For The Treatment Of Peanut Allergy Andrey S. Larionov, Ioanna Stavrakaki, Edwin Kim et al. · Journal of Allergy and Clinical Immunology Feb 2019 8
48 Detection of class‐specific antibodies against Micropolyspora faeni antigens in farmers’lung M. HUIZFNGA, Lubertus Berrens · Clinical & Experimental Allergy Mar 1985 8
49 Capsaicin treatment of idiopathic rhinitis: The new panacea? Jeroen B. van Rijswijk, Roy Gerth van Wijk · Current Allergy and Asthma Reports Mar 2006 7
50 Tolerability and Safety of Sublingual Immunotherapy in Patients with Tree Pollen Allergy in Daily Practice—An Open, Prospective, Non-Interventional Study Christoph Owenier, Cornelia Barnowski, Margret Leineweber et al. · Journal of Clinical Medicine Open access 25 Aug 2023 6

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.